IMMUNORHO

This brand name is authorized in Estonia, Lithuania, Malta, Tunisia, Turkey

Active ingredients

The drug IMMUNORHO contains one active pharmaceutical ingredient (API):

1 Anti-D (rh) immunoglobulin UNII 48W7181FLP - HUMAN RHO(D) IMMUNE GLOBULIN

Human anti-D immunoglobulin contains specific antibodies (IgG) against the Rh(D) antigen of human erythrocytes. It can also contain antibodies to other Rh antigens, e.g. anti-Rh C antibodies. The mechanism by which anti-D immunoglobulin suppresses immunisation to Rh(D) positive red cells is not known. Read about Anti-D (rh) immunoglobulin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J06BB01	Anti-D (rh) immunoglobulin	J Antiinfectives for systemic use → J06 Immune sera and immunoglobulins → J06B Immunoglobulins → J06BB Specific immunoglobulins
Discover more medicines within J06BB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1752656
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1086908
Country: MT	Medicines Authority	Identifier(s): AA128/00501
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 13043071
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8680972009083